Ipilimumab vs Vancomycin
Ipilimumab vs Vancomycin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Vancomycin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Vancomycin — 4-6 hours.
Chemical Properties
Molecular Formula: Vancomycin — C66H75Cl2N9O24.
Molecular Weight: Vancomycin — 1449.2500 g/mol.
Type: Ipilimumab — Antibody; Vancomycin — Small molecule.